--- title: "Artiva Biotherapeutics Metrics Guide" description: "Artiva Biotherapeutics Inc. revenue, margins, cash flow and balance sheet figures by fiscal year, taken from its SEC filings, with the ratios explained." canonical: https://www.getswoopr.com/stocks/companies/artiva-biotherapeutics-inc/financial-metrics/ source: "Swoopr Investment: https://www.getswoopr.com" --- # Artiva Biotherapeutics Inc. Financial Metrics Guide ## Direct Answer > Artiva Biotherapeutics Inc. reported revenue of $0 for the fiscal year ended December 31, 2025, net income of -$84 million, according to its SEC filings. Revenue fell 100.0% from the prior year. ## What Are Artiva Biotherapeutics Inc.'s Key Financial Figures? | Fiscal year | FY2025ended December 31, 2025 | FY2024ended December 31, 2024 | FY2023ended December 31, 2023 | | --- | --- | --- | --- | | Revenue | $0 | $251,000 | $33 million | | Operating income | -$90 million | -$67 million | -$31 million | | Operating margin | n/a | -26805.6% | -91.6% | | Net income | -$84 million | -$65 million | -$29 million | | Net margin | n/a | -26045.0% | -85.8% | | Operating cash flow | -$77 million | -$55 million | -$47 million | | Capital expenditures | $3 million | $642,000 | $3 million | | Free cash flow | -$79 million | -$56 million | -$51 million | Free cash flow (operating cash flow minus capital expenditures) was -$79 million against net income of -$84 million; cash generation covered reported earnings. ![Bar chart of Artiva Biotherapeutics Inc. revenue, operating income, net income for fiscal 2023 to 2025. In fiscal 2025, revenue was $0, operating income negative $90 million and net income negative $84 million.](https://www.getswoopr.com/images/charts/artiva-biotherapeutics-inc-metrics-revenue-profit.webp) *Artiva Biotherapeutics Inc. revenue, operating income and net income by fiscal year, from the figures in the table above. Select the chart to open it full size.* ![Line chart of Artiva Biotherapeutics Inc. operating margin and net margin for fiscal 2023 to 2025. In fiscal 2025, operating margin was n/a and net margin was n/a.](https://www.getswoopr.com/images/charts/artiva-biotherapeutics-inc-metrics-margins.webp) *Artiva Biotherapeutics Inc. operating margin and net margin by fiscal year: operating income and net income as a share of revenue. Select the chart to open it full size.* ![Bar chart of Artiva Biotherapeutics Inc. operating cash flow, capital expenditures, free cash flow for fiscal 2023 to 2025. In fiscal 2025, operating cash flow was negative $77 million, capital expenditures was $3 million, free cash flow was negative $79 million.](https://www.getswoopr.com/images/charts/artiva-biotherapeutics-inc-metrics-cash-flow.webp) *Artiva Biotherapeutics Inc. operating cash flow, capital expenditures and free cash flow by fiscal year. Select the chart to open it full size.* ## What Does Artiva Biotherapeutics Inc.'s Balance Sheet Show? | Cash and cash equivalents | $27 million | | --- | --- | | Long-term debt | Not reported | | Total assets | $131 million | | Total liabilities | $21 million | | Shareholders' equity | $110 million | | Current ratio | 8.6x | Balance sheet values are as of the end of fiscal 2025. Income statement figures describe a whole year; balance sheet figures describe a single day, so the two answer different questions. ## Where These Numbers Come From Every figure on this page is a value Artiva Biotherapeutics Inc. reported in its own SEC filings, read from the SEC's XBRL data (accession 0001193125-26-100135 for fiscal year 2025). Ratios are computed from those reported values. Figures were retrieved on October 7, 2026; a later amendment or a new annual report can change them, and the filing itself always takes precedence over this summary. Each fiscal year is labeled by the calendar year in which it ended, so a company that names the same period differently in its own filings (many retailers whose year ends in January) may use another label. A year is left out of the table when the SEC data set holds no value for it. A figure shown as "Not reported" means the company did not file a value under the standard tag Swoopr reads, not that the amount was zero. This page is educational and describes reported history only; it is not a forecast or a recommendation. ## Frequently Asked Questions ### What was Artiva Biotherapeutics Inc.'s revenue in fiscal 2025? Artiva Biotherapeutics Inc. reported revenue of $0 for the fiscal year ended December 31, 2025, according to its SEC filings. ### What is Artiva Biotherapeutics Inc.'s operating margin? Artiva Biotherapeutics Inc. did not report operating income under the standard tag for fiscal 2025, so Swoopr does not compute an operating margin; the income statement in its 10-K shows how it presents profit. ### How much free cash flow did Artiva Biotherapeutics Inc. generate? Operating cash flow of -$77 million less capital expenditures of $3 million gives free cash flow of -$79 million for fiscal 2025. ## References - [SEC EDGAR: Artiva Biotherapeutics, Inc. Form 10-K filed March 10, 2026](https://www.sec.gov/Archives/edgar/data/1817241/000119312526100135/artv-20251231.htm) - [SEC EDGAR: Artiva Biotherapeutics, Inc. annual and quarterly filings](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1817241&type=10-K) - [SEC: EDGAR application programming interfaces (XBRL frames and submissions data)](https://www.sec.gov/search-filings/edgar-application-programming-interfaces) ## Related Pages - [Artiva Biotherapeutics Inc. company dossier](https://www.getswoopr.com/stocks/companies/artiva-biotherapeutics-inc/) - [Artiva Biotherapeutics Inc. financial metrics](https://www.getswoopr.com/stocks/companies/artiva-biotherapeutics-inc/financial-metrics/) - [Artiva Biotherapeutics Inc. financial risk indicators](https://www.getswoopr.com/stocks/companies/artiva-biotherapeutics-inc/risks-monitoring/) - [Artiva Biotherapeutics Inc. business model and revenue mix](https://www.getswoopr.com/stocks/companies/artiva-biotherapeutics-inc/business-model/) - [Fundamental analysis guides](https://www.getswoopr.com/learn/fundamental-analysis/) [Swoopr Editorial Team](https://www.getswoopr.com/authors/swoopr-editorial-team/) Swoopr's editorial team produces independent investment education content. Content is for educational purposes only and does not constitute personalized investment advice. See our [editorial policy](https://www.getswoopr.com/legal/editorial-policy/) and [corrections policy](https://www.getswoopr.com/legal/corrections-policy/).